Profile | GDS5420 / 237248_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 3.23 | 3 |
GSM1296119 | B_lesional_pre-dose | 27.82 | 20 |
GSM1296076 | C_lesional_pre-dose | 6.8 | 6 |
GSM1296092 | D_lesional_pre-dose | 75.62 | 40 |
GSM1296103 | E_lesional_pre-dose | 1.01 | 1 |
GSM1296078 | F_lesional_pre-dose | 49.78 | 31 |
GSM1296107 | G_lesional_pre-dose | 111.21 | 42 |
GSM1296109 | H_lesional_pre-dose | 3.92 | 3 |
GSM1296080 | I_lesional_pre-dose | 14.71 | 15 |
GSM1296090 | J_lesional_pre-dose | 43.96 | 30 |
GSM1296074 | K_lesional_pre-dose | 34.91 | 28 |
GSM1296111 | L_lesional_pre-dose | 59.93 | 31 |
GSM1296099 | M_lesional_pre-dose | 14.65 | 15 |
GSM1296086 | O_lesional_pre-dose | 41.58 | 29 |
GSM1296117 | P_lesional_pre-dose | 34.57 | 22 |
GSM1296113 | Q_lesional_pre-dose | 30.46 | 18 |
GSM1296096 | R_lesional_pre-dose | 20.86 | 20 |
GSM1296105 | S_lesional_pre-dose | 115.22 | 43 |
GSM1296098 | T_lesional_pre-dose | 9.09 | 6 |
GSM1296101 | U_lesional_pre-dose | 4.39 | 4 |
GSM1296121 | V_lesional_pre-dose | 27.45 | 21 |
GSM1296088 | W_lesional_pre-dose | 18.45 | 18 |
GSM1296082 | X_lesional_pre-dose | 6.38 | 7 |
GSM1296115 | Y_lesional_pre-dose | 72.62 | 35 |
GSM1296084 | Z_lesional_pre-dose | 6.01 | 5 |
GSM1296072 | B_lesional_day8 | 46.85 | 28 |
GSM1296069 | L_lesional_day8 | 73.01 | 33 |
GSM1296071 | P_lesional_day8 | 79.81 | 35 |
GSM1296070 | Y_lesional_day8 | 88.99 | 37 |
GSM1296073 | V_lesional_day8 | 23.8 | 18 |
GSM1296034 | A_lesional_day15 | 20.47 | 17 |
GSM1296041 | G_lesional_day15 | 78.43 | 36 |
GSM1296035 | R_lesional_day15 | 6.96 | 9 |
GSM1296038 | U_lesional_day15 | 62.16 | 34 |
GSM1296047 | B_lesional_day15 | 76.31 | 35 |
GSM1296039 | E_lesional_day15 | 5.33 | 5 |
GSM1296042 | H_lesional_day15 | 16.53 | 13 |
GSM1296043 | L_lesional_day15 | 44.08 | 25 |
GSM1296037 | M_lesional_day15 | 41.86 | 27 |
GSM1296046 | P_lesional_day15 | 79.49 | 35 |
GSM1296044 | Q_lesional_day15 | 64.15 | 31 |
GSM1296045 | Y_lesional_day15 | 107.55 | 39 |
GSM1296025 | C_lesional_day15 | 88.72 | 40 |
GSM1296033 | D_lesional_day15 | 43.42 | 29 |
GSM1296027 | I_lesional_day15 | 116.72 | 46 |
GSM1296032 | J_lesional_day15 | 361.49 | 62 |
GSM1296024 | K_lesional_day15 | 73.34 | 38 |
GSM1296031 | W_lesional_day15 | 186.79 | 50 |
GSM1296028 | X_lesional_day15 | 90.47 | 40 |
GSM1296029 | Z_lesional_day15 | 27.44 | 23 |
GSM1296026 | F_lesional_day15 | 42.46 | 28 |
GSM1296030 | O_lesional_day15 | 30.27 | 27 |
GSM1296040 | S_lesional_day15 | 46.76 | 29 |
GSM1296036 | T_lesional_day15 | ||
GSM1296048 | V_lesional_day15 | 37.48 | 24 |
GSM1296059 | A_lesional_day43 | 16.31 | 17 |
GSM1296066 | G_lesional_day43 | 109.84 | 41 |
GSM1296060 | R_lesional_day43 | 25.58 | 22 |
GSM1296063 | U_lesional_day43 | 117.41 | 43 |
GSM1296064 | E_lesional_day43 | 13.2 | 13 |
GSM1296067 | H_lesional_day43 | 51.47 | 29 |
GSM1296062 | M_lesional_day43 | 57.29 | 33 |
GSM1296068 | Q_lesional_day43 | 191.52 | 49 |
GSM1296050 | C_lesional_day43 | 349.61 | 62 |
GSM1296057 | D_lesional_day43 | 168.14 | 50 |
GSM1296052 | I_lesional_day43 | 68.36 | 38 |
GSM1296054 | J_lesional_day43 | 114.2 | 43 |
GSM1296049 | K_lesional_day43 | 88.28 | 40 |
GSM1296055 | W_lesional_day43 | 135.26 | 45 |
GSM1296053 | X_lesional_day43 | 25.49 | 21 |
GSM1296058 | Z_lesional_day43 | 47.69 | 32 |
GSM1296051 | F_lesional_day43 | 80.96 | 39 |
GSM1296056 | O_lesional_day43 | 15.22 | 16 |
GSM1296065 | S_lesional_day43 | 209.96 | 53 |
GSM1296061 | T_lesional_day43 | 8.6 | 7 |
GSM1296095 | A_non-lesional_pre-dose | 4.39 | 4 |
GSM1296120 | B_non-lesional_pre-dose | 78.46 | 35 |
GSM1296077 | C_non-lesional_pre-dose | 144.36 | 48 |
GSM1296093 | D_non-lesional_pre-dose | 118.72 | 43 |
GSM1296104 | E_non-lesional_pre-dose | 33.1 | 24 |
GSM1296079 | F_non-lesional_pre-dose | 96.59 | 41 |
GSM1296108 | G_non-lesional_pre-dose | 269.77 | 57 |
GSM1296110 | H_non-lesional_pre-dose | 25.43 | 18 |
GSM1296081 | I_non-lesional_pre-dose | 879.91 | 77 |
GSM1296091 | J_non-lesional_pre-dose | 99.91 | 42 |
GSM1296075 | K_non-lesional_pre-dose | 152.62 | 49 |
GSM1296112 | L_non-lesional_pre-dose | 156.38 | 45 |
GSM1296100 | M_non-lesional_pre-dose | 41.9 | 28 |
GSM1296087 | O_non-lesional_pre-dose | 175.86 | 52 |
GSM1296118 | P_non-lesional_pre-dose | 179.9 | 49 |
GSM1296114 | Q_non-lesional_pre-dose | 38.58 | 23 |
GSM1296097 | R_non-lesional_pre-dose | 16.46 | 16 |
GSM1296106 | S_non-lesional_pre-dose | 93.73 | 39 |
GSM1296102 | U_non-lesional_pre-dose | 15.08 | 14 |
GSM1296122 | V_non-lesional_pre-dose | 91.84 | 38 |
GSM1296089 | W_non-lesional_pre-dose | 62.69 | 33 |
GSM1296083 | X_non-lesional_pre-dose | 267.04 | 57 |
GSM1296116 | Y_non-lesional_pre-dose | 157.06 | 46 |
GSM1296085 | Z_non-lesional_pre-dose | 113.15 | 43 |